Neuroimmunomodulators in Neuroborreliosis and Lyme Encephalopathy
Author(s) -
Elizabeth A. Eckman,
Javier PachecoQuinto,
Aimee Herdt,
John Halperin
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy019
Subject(s) - lyme neuroborreliosis , neuroborreliosis , medicine , lyme disease , immunology , borrelia burgdorferi , lyme , cerebrospinal fluid , encephalopathy , meningitis , pathology , antibody , pediatrics
Lyme encephalopathy, characterized by nonspecific neurobehavioral symptoms including mild cognitive difficulties, may occur in patients with systemic Lyme disease and is often mistakenly attributed to central nervous system (CNS) infection. Identical symptoms occur in many inflammatory states, possibly reflecting the effect of systemic immune mediators on the CNS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom